The subject of the invention is the genomic sequence and the nucleotide sequences encoding polypeptides of Chlamydia trachomatis, such as cellular envelope polypeptides, which are secreted or specific, or which are involved in metabolism, in the replication process or in virulence, polypeptides encoded by such sequences, as well as vectors including the said sequences and cells or animals transformed with these vectors. The invention also relates to transcriptional gene products of the Chlamydia trachomatis genome, such as, for example, antisense and ribozyme molecules, which can be used to control growth of the microorganism. The invention also relates to methods of detecting these nucleic acids or polypeptides and kits for diagnosing Chlamydia trachomatis infection. The invention also relates to a method of selecting compounds capable of modulating bacterial infection and a method for the biosynthesis or biodegradation of molecules of interest using the said nucleotide sequences or the said polypeptides. The invention finally comprises, pharmaceutical, in particular vaccine, compositions for the prevention and/or treatment of bacterial, in particular Chlamydia trachomatis, infections.

Download PDF
Document Preview
Document History
  • Publication: Aug 18, 2009
  • Application: Mar 2, 2006
    US US 36696506 A
  • Priority: Mar 2, 2006
    US US 36696506 A
  • Priority: Nov 30, 1998
    US US 20122898 A
  • Priority: Nov 4, 1998
    US US 10707798 P
  • Priority: Dec 17, 1997
    FR FR 9716034 A
  • Priority: Nov 28, 1997
    FR FR 9715041 A

Download Citation

Sign in to the Lens